Subodh J. Saggi, MD, MPH, FACP, FASNProfessor of MedicineDirector, Nephrology Fellowship ProgramSUNY Downstate Parkside Ambulatory DialysisSUNY Downstate Extracorporeal Therapies, and Kidney -Pancreas transplant programBrooklyn, NY 11203USA

• Genetic Testing for the Management of Kidney Disease.- Application of Artificial Intelligence and Machine Learning in Kidney Disease.- The Role of The Metabolism/Exposome In Chronic Kidney Disease: Discovery for Precision Nutrition Microbiome derived Metabolites in CKD and ESRD.- Psychological Factors Associated with Adjustment to Kidney Disease and Engagement in Novel Technologies.- Current Dietary Advances in Enhancing Adherence in ESRD Patients.- Current Strategies to enhance opportunities for ESRD patients to receive a transplant: Sarthak Virmani and Richard Formica .- Blood Pressure Measurement in Chronic Kidney Disease and End Stage Renal Disease Assessing Volume Overload in Patients on Dialysis.- Technologies to monitor dialysis dose, vascular access function, and improve toxin removal.- Technologies Transforming AV Fistula Creation: “Endo-AVF or Percutaneous-AVF”.- Delaying the Onset and Progression of CKD in People with Diabetes: Technology and Effectiveness in Achieving Glucose Control.- Strategies and technologies to advance kidney health from Kidney Health Initiative.- Current noninvasive technologies in interventions to control Hyperparathyroid bone diseases of CKD and ESRD.- Sudden Cardiac Death in End Stage Kidney Disease: Technologies for Determining Causes and Predicting Risk.- Current and Future Technologies to Enhance Acceptance of Peritoneal Dialysis.- Project ECHO: Building workforce capacity to improve care for patients with kidney disease.- Use of Artificial Intelligence/Machine Learning for Individualization of Drug Dosing in Dialysis Patients.- Sudden death and coronary artery disease in chronic kidney disease: Strategies to identify and target specific populations.

Subodh J. Saggi, MD, MPH, FACP, FASNProfessor of MedicineDirector, Nephrology Fellowship ProgramSUNY Downstate Parkside Ambulatory DialysisSUNY Downstate Extracorporeal Therapies, and Kidney -Pancreas transplant programBrooklyn, NY 11203USA

• Genetic Testing for the Management of Kidney Disease.- Application of Artificial Intelligence and Machine Learning in Kidney Disease.- The Role of The Metabolism/Exposome In Chronic Kidney Disease: Discovery for Precision Nutrition Microbiome derived Metabolites in CKD and ESRD.- Psychological Factors Associated with Adjustment to Kidney Disease and Engagement in Novel Technologies.- Current Dietary Advances in Enhancing Adherence in ESRD Patients.- Current Strategies to enhance opportunities for ESRD patients to receive a transplant: Sarthak Virmani and Richard Formica .- Blood Pressure Measurement in Chronic Kidney Disease and End Stage Renal Disease Assessing Volume Overload in Patients on Dialysis.- Technologies to monitor dialysis dose, vascular access function, and improve toxin removal.- Technologies Transforming AV Fistula Creation: “Endo-AVF or Percutaneous-AVF”.- Delaying the Onset and Progression of CKD in People with Diabetes: Technology and Effectiveness in Achieving Glucose Control.- Strategies and technologies to advance kidney health from Kidney Health Initiative.- Current noninvasive technologies in interventions to control Hyperparathyroid bone diseases of CKD and ESRD.- Sudden Cardiac Death in End Stage Kidney Disease: Technologies for Determining Causes and Predicting Risk.- Current and Future Technologies to Enhance Acceptance of Peritoneal Dialysis.- Project ECHO: Building workforce capacity to improve care for patients with kidney disease.- Use of Artificial Intelligence/Machine Learning for Individualization of Drug Dosing in Dialysis Patients.- Sudden death and coronary artery disease in chronic kidney disease: Strategies to identify and target specific populations.

Subodh J. Saggi, MD, MPH, FACP, FASNProfessor of MedicineDirector, Nephrology Fellowship ProgramSUNY Downstate Parkside Ambulatory DialysisSUNY Downstate Extracorporeal Therapies, and Kidney -Pancreas transplant programBrooklyn, NY 11203USA

• Genetic Testing for the Management of Kidney Disease.- Application of Artificial Intelligence and Machine Learning in Kidney Disease.- The Role of The Metabolism/Exposome In Chronic Kidney Disease: Discovery for Precision Nutrition Microbiome derived Metabolites in CKD and ESRD.- Psychological Factors Associated with Adjustment to Kidney Disease and Engagement in Novel Technologies.- Current Dietary Advances in Enhancing Adherence in ESRD Patients.- Current Strategies to enhance opportunities for ESRD patients to receive a transplant: Sarthak Virmani and Richard Formica .- Blood Pressure Measurement in Chronic Kidney Disease and End Stage Renal Disease Assessing Volume Overload in Patients on Dialysis.- Technologies to monitor dialysis dose, vascular access function, and improve toxin removal.- Technologies Transforming AV Fistula Creation: “Endo-AVF or Percutaneous-AVF”.- Delaying the Onset and Progression of CKD in People with Diabetes: Technology and Effectiveness in Achieving Glucose Control.- Strategies and technologies to advance kidney health from Kidney Health Initiative.- Current noninvasive technologies in interventions to control Hyperparathyroid bone diseases of CKD and ESRD.- Sudden Cardiac Death in End Stage Kidney Disease: Technologies for Determining Causes and Predicting Risk.- Current and Future Technologies to Enhance Acceptance of Peritoneal Dialysis.- Project ECHO: Building workforce capacity to improve care for patients with kidney disease.- Use of Artificial Intelligence/Machine Learning for Individualization of Drug Dosing in Dialysis Patients.- Sudden death and coronary artery disease in chronic kidney disease: Strategies to identify and target specific populations.